Xconomy Boston

Bruker Buys Bruker for Almost $1B

Rebecca Zacks12/4/07

Shares of Bruker BioSciences (NASDAQ: BRKR), a Billerica, MA-based scientific instruments maker, are climbing on yesterday’s announcement that the firm will acquire the Bruker BioSpin Group, which develops magnetic resonance core technology, for $914 million in cash and stock. The resulting company, which will be called Bruker Corporation, is projected to have more than 3,700 employees and 2007 pro forma revenue upwards of $900 million. Bruker BioSciences closed today at $12.15, up 31 percent from Friday’s close of $9.29.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.